i disagree in the statement that management is a joke.... Mr. Lampen was highlighted in IA top 25 of 2012 and that makes him very competent in my eyes...however i would like to see the board, mr lampen, and other insiders take a more focused effort in the stockholders by initiating a conference call, forward guidance, actual consistent profits on this business model because it is designed to be a cash machine, it is now a full year since they announced the acquisition of securities america and that needs to be showing the profit as well as the growth it as already inflected in the numbers. But the main thing is Dr Frost in my opinion...if the ticker doesn't have OPK in it he seems disinterested lately,,,now dont get me wrong he owns a ton of LTS but financials trade different than biotechs and when you do what you have done for OPK it would benefit us all..... I would love for him to be as involved with buying shares of LTS as he has OPK we would be over $5 now. Second... missing out on purchasing the Hartfords sale of Woodbury in my opinion was a missed opportunity for LTS to really make a splash again....but Mr Lampen will have to explain that ...well... if one calls he may explain it if he cares too... i myself am writing them a email to find out why.
Thank you for reaching out to them-we need answers and you are correct-they dont communicate with shareholders at all-it is very frustrating. IA Top 25? Who cares about that? we need profits and cash flow-thats what this board should be focused on 100% of the time-end of story